# EDURANT
> **NDA202022** · New Drug Application · Sponsor: JANSSEN PRODS · Approved 2011-05-20
## Drug
- **FDA Application Number:** NDA202022
- **Application type:** New Drug Application
- **Brand name:** EDURANT
- **Generic name:** RILPIVIRINE HYDROCHLORIDE
- **Active ingredients:** RILPIVIRINE HYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** JANSSEN PRODS
- **Manufacturer:** Janssen Products, LP
- **First approval:** 2011-05-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202022)
---
*AI Analytics · CC0 1.0*